Welcome : Guest
  • Only Report Titles
  • Titles & Keywords

BLOOD BANKING AND BLOOD PRODUCTS - A GLOBAL STRATEGIC BUSINESS REPORT   

Research Abstract

This report analyzes the worldwide markets for Blood Banking & Blood Products in US$ Million by the following Product Segments: Blood Components and Plasma Products (Whole Blood & Cellular Components, & Plasma Fractions), and Equipment, Blood Tests and Other Consumables (Includes blood screening and related QC function, but excludes patient diagnosis). The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for each region for the period 2007 through 2015. Also, a seven-year historic analysis is provided for these markets. The report profiles 207 companies, including leading blood banks such as AABB, America’s Blood Centers, American Red Cross, Canadian Blood Services, CorCell Companies, Inc., Cord Blood Registry, Japan Red Cross, Lifebank Corp, National Blood Foundation, New England Cord Blood Bank, Inc., New York Blood Center, and VITA 34 AG. Some of the leading players in Blood Bank Technology & Supplies also discussed in this report include Beckman Coulter Inc., Becton Dickinson and Company, BioMerieux SA, Caridian BCT, Inc., Chiron, CSL Behring LLC, Daxor Corporation, Fenwal Inc., Fresenius SE, Gen-Probe, Inc., Haemonetics Corp, Hemagen Diagnostics Inc., Immucor Inc., Kawasumi Laboratories, Inc., Olympus America, Inc., PharmaStem Therapeutics, Inc., Terumo Corporation, ThermoGenesis Corp., and Velico Medical, Inc. Leading Players discussed under the Plasma Fractionation segment include Baxter International Inc., Bio Products Laboratory, CSL Limited, CSL Bioplasma, Grifols, Kedrion, Laboratorie Francais du Fractionnement et des Biotechnologies, Octapharma, Sanquin, and Talecris Biotherapeutics. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

Code : MCP-1028
Price : $4500
Companies : 207
Pages : 905
Date : September 2010
Market Data Tables : 98

Complimentary Copy of Study Findings:


Request a Complimentary Copy of the Study’s Key Findings, Drivers, Trends, Program Sources, and Methodology.
Salutation:
First Name:
Last Name:
Email ID: (Domain Specific Email Required)
Company:
NOTE: Generic Email IDs such as AOL, Hotmail, Yahoo, Gmail, MSN etc. cannot be used

 TABLE OF CONTENTS

  BLOOD BANKING AND BLOOD PRODUCTS (Complete Report) Pages : 905   | $4500
 
  1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS.......16 $295  
   Study Reliability and Reporting Limitations.......1  
   Disclaimers.......2
Data Interpretation & Reporting Level.......2
  
   Quantitative Techniques & Analytics.......3
Product Definitions and Scope of Study.......3
Blood Components and Plasma Products.......3
  
   Whole Blood & Cellular Components.......4
WBCs.......4
RBCs.......4
Platelets.......4
Plasma Fractions.......4
Fresh Frozen Plasma.......4
  
   Albumin Fractions.......5
Factor VIII.......5
Factor IX and Factor IX Complex.......5
Fibrin/Thrombin.......5
Equipment, Blood Tests and Consumables.......5
Automated Analyzers for Blood Analysis.......5
  
   Blood Tests.......6
Consumables.......6
  
  2. MARKET OVERVIEW.......77 $1450  
   Healthcare Scares Propel the Market.......7
Blood Transfusion Worldwide: A Kaleidoscope of Stark Contrasts.......7
1$100
   Worldwide Blood Banking and Blood Products Market at a Glance (All figures are 2010
  estimates & CAGR is for the period 2007-2015).......8
Current & Future Analysis.......8
Analysis by Geographic Region.......8
1$100
   Analysis by Product Segment.......9
World Blood Components and Plasma Market Analysis in Units.......9
1$100
   Table 1: World Recent Past, Current & Future Analysis for Blood Components and Plasma by Region/Country – USA, Europe, Japan, and Rest of World Markets Independently Analyzed with Annual Consumption in Million Units for Years 2007 through 2015 (includes corresponding Graph/Chart).......101$350
   Table 2: World 9-Year Perspective for Blood Components and Plasma by Region/Country – Percentage Breakdown of Volume Consumption for USA, Europe, Japan, and Rest of World Markets for Years 2007, 2010 & 2015 (includes corresponding Graph/Chart).......111$350
   Red Blood Cells – A Key Blood Component and a Major Contributor.......12
Table 3: World Recent Past, Current & Future Analysis for Red Blood Cells by Region/Country – USA, Europe, Japan, and Rest of World Markets Independently Analyzed with Annual Consumption in Million Units for Years 2007 through 2015 (includes corresponding Graph/Chart).......12
1$350
   Table 4: World 9-Year Perspective for Red Blood Cells by Region/Country – Percentage Breakdown of Volume Consumption for USA, Europe, Japan, and Rest of World Markets for Years 2007, 2010 & 2015 (includes corresponding Graph/Chart).......131$350
  3. MARKET TRENDS & ISSUES.......148 $950  
   New Infections – A Continuous Threat.......14
Safety and Availability: The Core Issues.......14
1$100
   Decontamination: A Viable Process.......15
New Processes for Safer Blood Supply.......15
Innovative Procedures Help Blood Conservation.......15
Autologous Transfusion Strapping up for High Growth.......15
1$100
   Enzyme Converted Cells Set to Rule the Industry.......16
Blood Unavailability: Substitutes to the Rescue.......16
Transfusions: Hospitals Making Way for Others.......16
1$100
   Computer Identification Helps Patients.......17
SARS: A Case of Mistaken Identity?.......17
Pooling: Economical HIV Testing.......17
Private Cord Blood Banking: Flying High Despite Opposition.......17
Consolidation Whittles Down Number of Market Players.......17
1$100
   Table 5: Leading Players in the Global Blood Screening Market (2008) (includes corresponding Graph/Chart).......18

Table 6: Leading Players in the Global Plasma Derived Products Market (2008): Market Share in terms of Revenues for Baxter, CSL, Octapharma, Talecris and Grifols (includes corresponding Graph/Chart).......18
1$350
   Table 7: Market Shares of CSL Behring and Talecris in Select Plasma Product Markets in terms of Revenues (2008) (includes corresponding Graph/Chart).......19
Automation of Blood Banking – Nearing the Efficiency Frontier?.......19
Automated Instrumentation Taking the Front Seat.......19
1$350
   Table 8: World Market for Blood Bank Technology (2007): Percentage Breakdown of Revenues by Segment – Manual Blood Bag Systems, Automated Systems, Component Lab, Commercial Plasma, Blood Salvage, and Pathogen Inactivation (includes corresponding Graph/Chart).......20

Table 9: Leading Players in the World Market for Automated Collection of Blood Components using Apheresis Technology (2005 – A Historic Review): Percentage Breakdown of Revenues for Gambro, Baxter, Haemonetics, Fresenius, and Others (includes corresponding Graph/Chart).......20
Plasma Market: Automation Making Inroads.......20
The RBC Market – Slow to Catch Up.......20
1$350
   Automation of Testing – Yet to Mature.......21
Automation to Suffice Shortage Problems.......21
How Near to the Efficiency Frontier?.......21
1$100
  4. PRODUCT OVERVIEW.......2215 $1950  
   Blood Banking and Blood Products Industry.......22
Blood Components and Plasma Products.......22
Equipment, Blood Tests and Consumables.......22
Automated Analyzers for Blood Analysis.......22
Blood Tests.......22
1$100
   Consumables.......23
Blood Collection Equipment.......23
Blood Collection Monitors.......23
Blood Donor Couches.......23
Blood Processing Equipment.......23
Blood Bank Centrifuges.......23
Plasma Thawing.......23
1$100
   Blood Cell Separators.......24
Blood Storage Equipment.......24
Blood Bags.......24
Platelet Agitators.......24
Blood Bank Refrigerators.......24
Blood – A Primer.......24
Ionic Structure.......24
1$100
   Blood Components and their Applications.......251$100
   Blood Constituents.......26
Plasma.......26
Red Blood Cells (RBC).......26
1$100
   Blood Count.......27
Platelets.......27
1$100
   Table 10: Platelets (Leucodepleted) Issued by Select Region/ Agency (2005) (includes corresponding Graph/Chart).......28
White Blood Cells (WBC).......28
1$350
   Derivative Products of Blood or Plasma Fractions.......29
Plasma Protein and Fractionation.......29
The Need.......29
Fresh Frozen Plasma.......29
1$100
   Other Plasma Fractions.......30
Albumin Fractions.......30
Albumin Usage Rising in Profile, Wastage Worries Run Deep.......30
Immunoglobulins.......30
Table 11: Leading Countries in IVIg Usage Rates in Grams per 1000 Population (includes corresponding Graph/Chart).......30
1$350
   Hyper-Immune Immunoglobulin.......31
Factor VIII.......31
Table 12: Leading Players in World Market for Factor VIII (2006): Percentage Breakdown of Revenues for Baxter, Bayer (Kogenate), CSL Behring (Helixate) and Wyeth (includes corresponding Graph/Chart).......31
Factor IX and Factor IX Complex.......31
Fibrin/Thrombin.......31
1$350
   Consumption of Blood Based on Type of Surgery/ Accident (In Units).......32
Table 13: World Market for Plasma Derivatives (2009): Percentage Breakdown of Revenues by Region/Country – USA, Europe, Asia-Pacific, Latin America, and Rest of World (includes corresponding Graph/Chart).......32

Table 14: World Market for Plasma Derivatives (2006): Percentage Breakdown of Revenues by Product Type – IVIg, Factor VIII, Albumin, Hyperimmunes, Factor IX and Others (includes corresponding Graph/Chart).......32
1$350
   Table 15: Plasma Collection in Select Countries in Thousand Liters (includes corresponding Graph/Chart).......33
Recombinant Products.......33
Therapeutic Uses of Plasma Products.......33
1$350
   Albumin Products.......34
Immunoglobulins.......34
Intravenous Immunoglobulin (IVIg).......34
Normal Immunoglobulin (IMIg).......34
CMV Immunoglobulin.......34
1$100
   Hepatitis B Immunoglobulin.......35
Rh (D) Immunoglobulin.......35
Tetanus Immunoglobulin IM.......35
Zoster Immunoglobulin.......35
Plasma Derived Coagulant Products.......35
Biostate®.......35
Ceprotin®.......35
1$100
   Factor VII Concentrate.......36
Factor XI Concentrates.......36
Feiba VH® Inhibitor Treatment.......36
Fibrogammin P®.......36
Monofix®-VF.......36
ProthrombinexTM-HT.......36
Thrombotrol®-VF.......36
1$100
  5. BLOOD COLLECTION METHODS.......3713 $1450  
   Banking the Natural Blood Resources.......37
Blood Banks.......37
Blood Banking.......37
Blood Transfusion.......37
Role of Blood Banks.......37
Blood Donor: The Epicenter of the Process.......37
1$100
   Eligibility Criteria for the Donor.......38
The Basics of Blood Donation – Myths Exploded & Other Facts.......38
1$100
   Table 16: Active Donors of Whole Blood and Apheresis per 1,000 of Population by Country/Agency (includes corresponding Graph/Chart).......391$350
   Table 17: Percentage Breakdown of Apheresis and Whole Blood Donations by Country (2005) (includes corresponding Graph/Chart).......40
Collection Methods.......40
Blood Donation: The Process.......40
Types of Blood Donation.......40
Directed Blood Donations.......40
1$350
   Autologous Blood Donation.......41
Alternative Usage of Patient’s Own Blood.......41
General Blood Donation.......41
Hemodilution.......41
Wound Drainage.......41
Cell Saver.......41
1$100
   The Method.......42
Blood Salvaging.......42
Blood Collection Centers.......42
Blood Collection Management System.......42
A Historical Retrospective.......42
1$100
   Blood Collection Centers.......43
Types of Blood Collection Centers.......43
Cord Blood Banks.......43
Profit Collection Centers.......43
Military Blood Banks.......43
Hospital Blood Banks.......43
1$100
   Community Blood Banks.......44
Non-Profit Collection Centers.......44
Blood Processing.......44
1$100
   Blood Typing.......45
Rh Blood Group System.......45
ABO Blood Group System.......45
1$100
   Blood Types and their Compatibility.......46
Table 18: Occurrence of Blood Groups Worldwide (In %) (includes corresponding Graph/Chart).......46
Blood Test.......46
1$350
   Blood Culture.......47
The Costs.......47
History of Blood Banking.......47
3$300
  6. THE CHANGING LANDSCAPE OF TRANSFUSION TECHNOLOGIES & TESTS.......503 $295  
   Blood Transfusion: A Backdrop.......50
Massive Transfusion.......50
Complications and Risks Due to Transfusion.......50
1$100
   Circulatory Overload.......51
Graft Versus Host Disease (GVHD).......51
Haemolytic Transfusion Reactions.......51
Iron Overload.......51
Bacterial Contamination.......51
Thrombophlebitis.......51
1$100
   Allergic Reactions.......52
Air Embolism.......52
Hyperkalaemia.......52
Changing Role of Blood Banking Technology.......52
1$100
  7. BLOOD TRANSFUSION: THE PROCESS, TESTS/TECHNOLOGIES.......53   
   Cross Matching.......53
Blood Donor/Recipient Screening.......53
Blood Typing.......53
Leukoreduction.......53
1$100
   Leukocyte Reduction Specification Standards/Filters.......54
Coombs Test.......54
1$100
  8. ALTERNATIVES TO BLOOD TRANSFUSION: A REAL THREAT TO THE INDUSTRY.......553 $295  
   Bloodless Surgery.......55
Therapeutic Apheresis.......55
Plasmapheresis.......55
1$100
   Plateletpheresis.......56
Leukapheresis.......56
Volume Expanders.......56
Colloids.......56
Albumin.......56
Dextrans.......56
1$100
   Hydroxyethyl Starch.......57
Crystalloids.......57
Blood Growth Factor Therapies – Newer Alternatives to Transfusion.......57
1$100
  9. BLOOD SUBSTITUTES.......583 $295  
   Blood Substitutes Under Development by Manufacturers.......581$100
   Synthetic Blood Manufacturers/Developers.......59
Alliance Pharmaceuticals Corp. (USA).......59
Biopure Corporation (USA).......59
1$100
   Enzon Pharmaceuticals (USA).......60
Hemosol Inc. (Canada).......60
Northfield Laboratories Inc. (USA).......60
Synthetic Blood International, Inc. (USA).......60
1$100
  10. PRODUCT INTRODUCTIONS/INNOVATIONS.......6110 $595  
   Fenwal Receives US FDA Clearance for Fenwal Amicus® Separator System.......61
FamilyCord Introduces New More Efficient and Safe Cord Blood Collection Kit.......61
BD Unveils BD Microtainer® MAP Microtube.......61
1$100
   Pall Releases Advanced Blood Filter.......621$100
   Fenwal Responds to Haemonetics’ New Lawsuit Against Alyx® System.......63
CaridianBCT Rolls Out RBCX Protocol.......63
1$100
   ITL Launches TEGO™ Animal Blood Collection Kit.......64
Fenwal to Launch Modified ALYX Kit.......64
QIAGEN Launches New QIAsafe DNA Blood Products.......64
1$100
   Gambro Introduces New Prismaflex eXeed™ System.......65
AnaSpec Unveils ‘SensoLyte® Rh110 Plasmin Activity Assay Kit.......65
1$100
   Typenex® Medical Rolls Out New Barcode Blood Band.......66
Olympus Introduces Hemoglobin A1c APT Reagent for Chemistry Analyzer System.......66
BD Diagnostics Launches BD BACTEC™ FX Blood Culture System.......66
1$100
   Beckman Coulter Launches UniCel DxH 800 Coulter® Cellular Analysis System.......671$100
   Diazyme Secures FDA Clearance for Marketing Liquid Stable Enzymatic Lithium
  Test.......68
ThermoGenesis Launches New Range of Veterinary POC Products.......68
1$100
   Prometheus Develops First Blood Test for IBS Diagnosis.......69
CaridianBCT Introduces ‘Atreus® 3C Whole Blood Processing System’.......69
GeneNews Unveils ColonSentry™ for Diagnosing Colorectal Cancer.......69
1$100
   Haemonetics Upgrades PCS®2 System with Quicker Plasma Collection Software.......701$100
  11. PRODUCT INNOVATIONS/LAUNCHES IN RECENT PAST – A PERSPECTIVE BUILDER.......714 $395  
   Olympus Launches AU680® Chemistry Analyzer.......71
Haemonetics Software Expands Symphony 2.0 Software with New Module 71 Gen-Probe
  Introduces APTIMA® HPV Assay.......71
1$100
   Olympus Life Science Europa Introduces Automated HbA1c Assay.......72
Haemonetics Unveils New Plasma Collection Software.......72
Pall Unveils Acrodose™ PLus System.......72
Z-Medica Rolls Out Rapid Blood Clotting Products in the Consumer Market.......72
1$100
   Dade Behring Launches the Quadriga BeFree System.......73
Swedish Inventors Develop New Processing System.......73
Canada Invents New Method for Monitoring Blood and Blood Products.......73
Terumo Launches Improvised Bags For Safe Blood Collection.......73
1$100
   Haemonetics Launches Cymbal Automated Blood Collection System.......741$100
  12. PRODUCT APPROVALS IN THE RECENT PAST.......75   
   Cerus Receives CE Mark Approval for the Intercept Blood System for Platelets.......75
Haemonetics Wins FDA Approval for the ACP 215 System.......75
Biomerieux’ Polycarbonate BacT/ALERT Receives US FDA Clearance.......75
1$100
   Pall’s eBDS Receives Green Signal from FDA.......76
CardioPAT™ Surgical Blood Salvage System.......76
PCS® 2 – Set to Enhance Plasma Quality.......76
Dade Behring’s D-Dimer Assay Strapping up for Roll Out.......76
1$100
  13. RECENT INDUSTRY ACTIVITY.......7731 $1950  
   HemaCare Signs Two New Blood Service Contracts.......77
Cord Blood Acquires Majority Stake in Stellacure.......77
1$100
   Haemonetics Gains Rights to Alba’s Full Line of Blood Typing Reagents.......78
ThermoGenesis Inks Deal with Fenwal and Enters Asian Markets.......78
1$100
   CaridianBCT Obtains FDA Approval for New 6.0 Trima Accel® Automated Blood Collection
  System.......79
American Red Cross Inks 3-Year Deal with ITL.......79
1$100
   FDA Grants 510(K) Clearance for Expanded Use of Haemonetics.......80
ThermoGenesis and GE Healthcare Enter into Distribution Deal.......80
1$100
   Daxor’s Idant Labs Bags Blood Banking Contract from RMSB&G.......81
Beckman Coulter Agrees to Distribute CellaVision Digital Morphology Products.......81
1$100
   Haemonetics to Acquire Global Med.......82
Therapure Biopharma Inks Long Term Pact with LFB Biomedicaments.......82
1$100
   PathCare Establishes New Cord Blood Stem Cell Banking Facility.......83
MRHC Obtains License for SafeTrace Tx Solution of Global Med.......83
Life Technologies to Acquire AcroMetrix.......83
1$100
   Fenwal Secures FDA Approval for New Platelet Additive Solution.......84
Daxor Sells Blood Volume Analyzer to MUSC.......84
1$100
   Heska Enters into a Supply Agreement with Roche Diagnostics.......85
BLOOD Bank of Alaska Obtains License for Mediware’s LifeTrak Technology.......85
1$100
   Europe and the US Expand Blood Banking Agreement.......86
Daxor to Provide BVA-100 Blood Volume Analyzer to Durham VA Medical Center.......86
Pfizer Acquires Wyeth.......86
1$100
   Baxter Inaugurates New BLOOD Plasma Fractionation Facility in Vienna.......87
ProMetic Acquires Majority Shareholding in PRDT.......87
BD Diagnostics Bags FDA Approval for BD Vacutainer® Rapid Serum Tube.......87
1$100
   Cadila to Establish Biosimilars Manufacturing Plant.......88
China Biologic to Collaborate with IBT on Research & Development.......88
Abbott Obtains FDA Approval for Abbott Prism HIV O Plus Test.......88
1$100
   Gen-Probe to Establish Independent New Firm for Industrial Testing.......891$100
   Haemonetics Acquires SEBRA Blood Collection & Processing Unit.......901$100
   Beckman Coulter Acquires Lab-Based Diagnostics Business of Olympus.......91
Daxor to Provide BVA-100 Blood Volume Analyzer to Pacific Cardiology.......91
Golden Meditech and Fenwal to Establish a Blood Collection Joint Venture in
  China.......91
1$100
   PRCS Inaugurates State-of-the-Art Blood Bank.......92
CSL and Talecris Terminate Merger Agreement.......92
Immucor Inks 5-Year Deal with Alverno.......92
1$100
   Gen-Probe Acquires Tepnel and Renews Partnership with Novartis.......93
Haemonetics Takes Over Neoteric Technology.......93
1$100
   Haemonetics Acquires Altivation Software.......941$100
   PacifiCord Sets Up Cord Blood Banking Facility in Irvine.......95
China Biologic Acquires 35% Stake in Xi`an Huitian Blood Products.......95
Biocell and Cellsense Merge.......95
Octapharma Plans to Set Up Fractionation Facility.......95
1$100
   Therapure BioPharma Inks Development Services Deal with LFB Biotechnologies.......96
Strassenburg and CordLife to Establish Blood Banking Facility in Kolkata,
  India.......96
Biotest Acquires Blood Plasma Collection Center from Talecris.......96
NCRM and Jeevan Stem Cell Bank Signs MoU for Cord Blood Stem Cells Research .......96
1$100
   TCH of Tahlequah Acquires Daxor’s BVA-100 Blood Volume Analyzer.......97
Gen-Probe Expands and Extends Blood Screening Alliance with Novartis.......97
1$100
   Celestial Biologicals Collaborates With GE Healthcare for Indian Market.......98
China Biologic to Purchase Stake in Dalin.......98
Cerus Enters Into Deal with Fenwal.......98
1$100
   Bennnett, Coleman Picks Up Minority Stake in Stem One Biologicals.......99
Cryo-Cell Renews Exclusive Retailer Agreement with Upromise®.......99
Pantheon China to Take Over China Cord Blood Services.......99
1$100
   United Blood Services to Divest Jackson Operations to Mississippi Blood
  Services.......100
ITL Signs Agreement with Blood Centers of America.......100
CaridianBCT Mirasol PRT System Receives CE Mark Approval.......100
CaridianBCT Signs Deal with American Red Cross for Automated Blood Collection
  Technology.......100
1$100
   Genzyme Japan to Acquire Lymphoglobuline Marketing from CSL Behring.......101
Biotest Diagnostics and GSABC Ink a Deal.......101
1$100
   Blood Cell Storage Inks Option Agreement With CaridianBCT.......102
CBB Inaugurates Donor Facility In Indio.......102
CSL to Acquire Talecris.......102
1$100
   Novartis Diagnostics Gains FDA Clearance for PROCLEIX® ULTRIO® Assay.......103
ViaCord to Collaborate with Mia Hamm Foundation.......103
1$100
   Octapharma to Take Over Plasma Centers from International BioResources.......104
America's Blood Centers and MDA Ink a Contingency Deal.......104
Piramal Healthcare Enters into an Agreement with PlasmaSelect.......104
1$100
   Grifols Secures Commercial Loan for Purchasing Plasma Centres.......105
Cytori Inks Supplying Agreement with Biohellenika.......105
Animal Blood Bank and Midwest Animal Blood Services Merge to Form Animal Blood
  Resources.......105
Gambro Gains FDA Approval for Sale of Atreus®.......105
1$100
   Cerus Signs Agreement for INTERCEPT Platelet System Supply.......106
Haemonetics Teams Up with Octapharma for Plasma Collection Technology.......106
Gambro Inks Deal with S.C.M to Divest Its Bloodline manufacturing Unit.......106
1$100
   Octapharma Acquires PVG.......1071$100
  14. CORPORATE ACTIVITY IN RECENT PAST – A PERSPECTIVE BUILDER.......10831 $1950  
   Corporate Activity In Recent Past – A Perspective Builder.......10831$1950
  15. FOCUS ON SELECT GLOBAL PLAYERS.......13914 $950  
   Leading Blood Banks.......139
AABB (USA).......139
America’s Blood Centers (USA).......139
American Red Cross (USA).......139
1$100
   Canadian Blood Services (Canada).......140
CorCell Companies Inc. (USA).......140
1$100
   Cord Blood Registry (USA).......141
Japan Red Cross Society (Japan).......141
Lifebank Corp. (Canada).......141
1$100
   National Blood Foundation (USA).......142
New England Cord Blood Bank, Inc. (USA).......142
New York Blood Center (USA).......142
1$100
   VITA 34 AG (Germany).......143
Leading Players in Blood Bank Technology and Supplies.......143
Beckman Coulter, Inc. (USA).......143
Becton, Dickinson and Company (USA).......143
BioMerieux SA (France).......143
1$100
   Caridian BCT, Inc (USA).......144
Chiron (USA).......144
1$100
   CSL Behring LLC (USA).......145
Daxor Corporation (USA).......145
Fenwal Inc., (USA).......145
1$100
   Fresenius SE (Germany).......146
Gen-Probe, Inc. (USA).......146
1$100
   Haemonetics Corp. (USA).......147
Hemagen Diagnostics Inc. (USA).......147
Immucor Inc. (USA).......147
1$100
   Kawasumi Laboratories, Inc. (Japan).......148
PharmaStem Therapeutics, Inc. (USA).......148
1$100
   Terumo Corp. (Japan).......149
ThermoGenesis Corp. (USA).......149
Velico Medical, Inc. (USA).......149
1$100
   Leading Players in Plasma Fractionation.......150
Baxter International Inc. (USA).......150
Bio Products Laboratory (UK).......150
CSL Limited (Australia).......150
CSL Bioplasma (Australia).......150
1$100
   Grifols (Spain).......151
Kedrion (Italy).......151
Laboratoire Français du Fractionnement et des Biotechnologies (France).......151
1$100
   Octapharma (Switzerland).......152
Sanquin (The Netherlands).......152
Talecris Biotherapeutics (USA).......152
1$100
  16. GLOBAL MARKET PERSPECTIVE.......153   
   Table 19: World Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Geographic Region – USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......1531$350
   Table 20: World Historic Review for Blood Banking and Blood Products by Geographic Region – USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart).......1541$350
   Table 21: World 10-Year Perspective for Blood Banking and Blood Products by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).......1551$350
   Table 22: World Recent Past, Current & Future Analysis for Blood Components and Plasma Products by Geographic Region - USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......1561$350
   Table 23: World Historic Review for Blood Components and Plasma Products by Geographic Region – USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart).......1571$350
   Table 24: World Recent Past, Current & Future Analysis for Blood Components and Plasma Products by Product Group – Whole Blood & Cellular Components, and Plasma Fractions Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......1581$350
   Table 25: World Historic Review for Blood Components and Plasma Products by Product Group – Whole Blood & Cellular Components, and Plasma Fractions Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart).......1591$350
   Table 26: World 10-Year Perspective for Blood Components and Plasma Products by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).......1601$350
   Table 27: World 10-Year Perspective for Blood Components and Plasma Products by Product Segment – Percentage Breakdown of Value Sales for Whole Blood & Cellular Components, and Plasma Fractions Markets for Years 2005, 2010 & 2015.......1611$350
   Table 28: World Recent Past, Current & Future Analysis for Whole Blood & Cellular Components by Geographic Region – USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......1621$350
   Table 29: World Historic Review for Whole Blood & Cellular Components by Geographic Region – USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart).......1631$350
   Table 30: World 10-Year Perspective for Whole Blood & Cellular Components by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).......1641$350
   Table 31: World Recent Past, Current & Future Analysis for Plasma Fractions by Geographic Region – USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......1651$350
   Table 32: World Historic Review for Plasma Fractions by Geographic Region – USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart).......1661$350
   Table 33: World 10-Year Perspective for Plasma Fractions by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).......1671$350
   Table 34: World Recent Past, Current & Future Analysis for Equipment, Blood Tests and Other Consumables by Geographic Region – USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......1681$350
   Table 35: World Historic Review for Equipment, Blood Tests and Other Consumables by Geographic Region – USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart).......1691$350
   Table 36: World 10-Year Perspective for Equipment, Blood Tests and Other Consumables by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).......1701$350
  17. THE UNITED STATES.......1719 $2450  
   A. Market Analysis.......171
Current and Future Analysis.......171
Market Trends.......171
Recession Impacts Blood Bank Reserves.......171
US Blood Collection & Supply Profile.......171
1$100
   Blood Group Distribution.......172
Table 37: US Market for Blood Banking and Blood Products: Percentage Break up of Blood Group by Rh Factor (includes corresponding Graph/Chart).......172
1$350
   Table 38: Percentage Break up of Rh Blood Types in the US by Racial Group.......173
Blood Donated and Transfused Every Year.......173
Males Form the Major Chunk of Donors.......173
Cost of Blood.......173
SARS Scares: Blood Banks Feel the Heat.......173
1$350
   Blood and Blood Preparations: A Recent Past Review of Trade Statistics.......174
Table 39: US Blood and Blood Preparations Market (2006 & 2007): Major Import Sources by Country – Germany, UK, Canada, Switzerland, Belgium and Others (In US$ Million) (includes corresponding Graph/Chart).......174

Table 40: US Blood and Blood Preparations Market (2006 & 2007): Major Export Destinations by Country – Germany, Netherlands, UK, Switzerland, Canada and Others (In US$ Million) (includes corresponding Graph/Chart).......174
1$350
   US Blood Components and Plasma Market Analysis in Units.......175
Table 41: US Recent Past, Current & Future Analysis for Blood Components and Plasma by Product Category – Red Blood Cells (RBCs), Platelets, and Fresh Frozen Plasma Markets Independently Analyzed with Annual Consumption in Million Units for Years 2007 through 2015 (includes corresponding Graph/Chart).......175

Table 42: US Historic Review for Blood Components and Plasma by Product Category – Red Blood Cells (RBCs), Platelets, and Fresh Frozen Plasma Markets Independently Analyzed with Annual Consumption in Million Units for Years 2001 through 2006 (includes corresponding Graph/Chart).......175
1$350
   Table 43: US 10-Year Perspective for Blood Components and Plasma by Product Category – Percentage Breakdown of Volume Consumption for Red Blood Cells (RBCs), Platelets, and Fresh Frozen Plasma for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).......176
Regulations Control Plasma Collection Industry.......176
1$350
   B. Market Analytics.......177
Table 44: US Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/ Segment – Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......177
1$350
   Table 45: US Historic Review for Blood Banking and Blood Products by Product Group/Segment – Blood Components and Plasma Products (Whole Blood and Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart).......1781$350
   Table 46: US 10-Year Perspective for Blood Banking and Blood Products by Product Group/Segment – Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).......1791$350
  18. CANADA.......1805 $950  
   A. Market Analysis.......180
Current and Future Analysis.......180
Blood Facts.......180
Bleeding Disorders – A Major Threat.......180
The ‘CSA-Z902-04’ – A Comprehensive Voluntary Blood Safety Standard.......180
1$100
   Blood and Blood Preparations: Import & Export Scenario in the Recent Past.......181
Table 47: Canadian Blood and Blood Preparations Market (2006 & 2007): Major Import Sources by Country – US, The Netherlands, Switzerland, Belgium, Italy and Others (In US$ Million) (includes corresponding Graph/Chart).......181

Table 48: Canadian Blood and Blood Preparations Market (2006 & 2007): Major Export Destinations by Country – US, France, Chile, Belgium, Germany and Others (In US$ Million) (includes corresponding Graph/Chart).......181
1$350
   B. Market Analytics.......182
Table 49: Canadian Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Segment – Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......182
1$350
   Table 50: Canadian Historic Review for Blood Banking and Blood Products by Product Group/Segment – Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart).......1831$350
   Table 51: Canadian 10-Year Perspective for Blood Banking and Blood Products by Product Group/Segment – Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).......1841$350
  19. JAPAN.......1855 $950  
   A. Market Analysis.......185
Current and Future Analysis.......185
Japan Witnesses Surge in Imported Blood Products.......185
Growing Market for Fresh Frozen Plasma.......185
Growing Use of Imported Albumin-Based Blood Products.......185
1$100
   The Goal of Self-Sufficiency.......1861$100
   B. Market Analytics.......187
Table 52: Japanese Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Segment – Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......187
1$350
   Table 53: Japanese Historic Review for Blood Banking and Blood Products by Product Group/Segment – Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart).......1881$350
   Table 54: Japanese 10-Year Perspective for Blood Banking and Blood Products by Product Group/Segment – Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).......1891$350
  20. EUROPE.......19013 $3450  
   A. Market Analysis.......190
Current & Future Analysis.......190
European Blood Banking and Blood Products Market at a Glance (All figures are 2010
  estimates & CAGR is for the period 2007-2015).......190
Market Trends and Issues.......190
Legislations on Payment for Donation Restrict Donors.......190
1$100
   Government’s Check on Healthcare Costs Pressurizes BCT Manufacturers.......191
Purchasing System Witnesses Modifications.......191
EU Nations Marching Towards Self-Sufficiency in Blood and Blood Products.......191
1$100
   Table 55: Blood Donation Rates in Europe by Geographic Region: 2006 (includes corresponding Graph/Chart).......192
Blood Banking Devices Market.......192
1$350
   Table 56: European Recent Past, Current & Future Analysis for Blood Banking Devices – Manual Blood Collection, Apheresis, and Autologous Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......1931$350
   Table 57: European Historic Review for Blood Banking Devices – Manual Blood Collection, Apheresis, and Autologous Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart).......194

Table 58: European 10-Year Perspective for Blood Banking Devices by Product Segment – Manual Blood Collection, Apheresis, and Autologous Devices Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).......194
1$350
   Table 59: European Blood Banking Devices Market (2007): Percentage Breakdown of Value Sales by Geographic Region for France, Germany, Italy, UK, Spain and Rest of Europe (includes corresponding Graph/Chart).......195
A Snapshot of Health Care Systems Across Select EU Countries.......195
France.......195
Germany.......195
1$350
   Italy.......196
The UK.......196
Spain.......196
1$100
   B. Market Analytics.......197
Table 60: European Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Geographic Region – France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......197
1$350
   Table 61: European Historic Review for Blood Banking and Blood Products by Geographic Region – France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart).......1981$350
   Table 62: European Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/ Segment – Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......1991$350
   Table 63: European Historic Review for Blood Banking and Blood Products by Product Group/Segment – Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart).......2001$350
   Table 64: European 10-Year Perspective for Blood Banking and Blood Products by Geographic Region – Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).......2011$350
   Table 65: European 10-Year Perspective for Blood Banking and Blood Products by Product Group/Segment – Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).......2021$350
  20a. FRANCE.......2033 $950  
   A. Market Analysis.......203
Current and Future Analysis.......203
B. Market Analytics.......203
Table 66: French Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/ Segment – Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......203
1$350
   Table 67: French Historic Review for Blood Banking and Blood Products by Product Group/Segment – Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart).......2041$350
   Table 68: French 10-Year Perspective for Blood Banking and Blood Products by Product Group/Segment – Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).......2051$350
  20b. GERMANY.......2063 $950  
   A. Market Analysis.......206
Current and Future Analysis.......206
B. Market Analytics.......206
Table 69: German Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Segment – Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......206
1$350
   Table 70: German Historic Review for Blood Banking and Blood Products by Product Group/Segment – Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart).......2071$350
   Table 71: German 10-Year Perspective for Blood Banking and Blood Products by Product Group/Segment – Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).......2081$350
  20c. ITALY.......2093 $950  
   A. Market Analysis.......209
Current and Future Analysis.......209
B. Market Analytics.......209
Table 72: Italian Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group /Segment – Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......209
1$350
   Table 73: Italian Historic Review for Blood Banking and Blood Products by Product Segment – Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart).......2101$350
   Table 74: Italian 10-Year Perspective for Blood Banking and Blood Products by Product Group/ Segment – Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).......2111$350
  20d. THE UNITED KINGDOM.......2124 $950  
   A. Market Analysis.......212
Current and Future Analysis.......212
Blood Requirements.......212
1$100
   B. Market Analytics.......213
Table 75: The UK Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/ Segment – Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......213
1$350
   Table 76: The UK Historic Review for Blood Banking and Blood Products by Product Group/Segment – Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumable Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart).......2141$350
   Table 77: The UK 10-Year Perspective for Blood Banking and Blood Products by Product Group/Segment – Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).......2151$350
  20e. SPAIN.......2163 $950  
   A. Market Analysis.......216
Current and Future Analysis.......216
B. Market Analytics.......216
Table 78: Spanish Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/ Segment – Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding graph/Chart).......216
1$350
   Table 79: Spanish Historic Review for Blood Banking and Blood Products by Product Group/Segment – Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart).......2171$350
   Table 80: Spanish 10-Year Perspective for Blood Banking and Blood Products by Product Group/ Segment – Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).......2181$350
  20f. RUSSIA.......2193 $950  
   Market Analysis.......219
Table 81: Russian Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/ Segment – Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......219
1$350
   Table 82: Russian Historic Review for Blood Banking and Blood Products by Product Group/Segment – Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart).......2201$350
   Table 83: Russian 10-Year Perspective for Blood Banking and Blood Products by Product Group/Segment – Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).......2211$350
  20g. REST OF EUROPE.......2224 $950  
   A. Market Analysis.......222
Current and Future Analysis.......222
Denmark – High Participation and Consumption of Blood.......222
1$100
   B. Market Analytics.......223
Table 84: Rest of Europe Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Segment – Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......223
1$350
   Table 85: Rest of Europe Historic Review for Blood Banking and Blood Products by Product Group/Segment – Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart).......2241$350
   Table 86: Rest of Europe 10-Year Perspective for Blood Banking and Blood Products by Product Group/Segment – Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).......2251$350
  21. ASIA-PACIFIC.......22611 $1995  
   A. Market Analysis.......226
Current and Future Analysis.......226
ASEAN – Striding Towards Standardization of Blood Supply.......226
China – A Key Market.......226
Blood Products Industry – An Overview.......226
1$100
   Performance Review.......2271$100
   Volume Declines But Revenues Shoot Up in Chinese Blood Products Market.......228
Government Wakes Up to Realities.......228
Table 87: Chinese Market for Blood Banking and Blood Products: Percentage Breakdown of Blood Group by Type – A, B, O, and AB (includes corresponding Graph/Chart).......228
1$350
   Table 88: Chinese Market for Blood Banking and Blood Products: Percentage Breakdown of Blood Donor by Gender – Male and Female.......229

Table 89: Chinese Blood Banking and Blood Products Market: Percentage Breakdown of Blood Donor by Age Group – 16-20, 21-30, 31-40, 41-50, 51-60, & 61-70 (includes corresponding Graph/Chart).......229
India.......229
Blood Banking Equipment Market on the Rise.......229
Tube Sealers and Blood Bags Dominate the Market.......229
1$350
   Recent Trends in the Market.......230
Indian Blood Banking Market Witnesses Major Transformations.......230
1$100
   Market Growth – Influencing Factors.......231
Increased Awareness Drives Voluntary Blood Donations in India.......231
Competitive Scenario.......231
1$100
   Regularization of Indian Cord Blood Banks.......2321$100
   Australia.......233
Role of National Blood Authority.......233
Indonesia.......233
1$100
   B. Market Analytics.......234
Table 90: Asia-Pacific Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Segment – Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......234
1$350
   Table 91: Asia-Pacific Historic Review for Blood Banking and Blood Products by Product Segment – Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart).......2351$350
   Table 92: Asia-Pacific 10-Year Perspective for Blood Banking and Blood Products by Product Group/Segment – Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).......2361$350
  22. LATIN AMERICA.......2373 $950  
   A. Market Analysis.......237
Current and Future Analysis.......237
B. Market Analytics.......237
Table 93: Latin American Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Segment – Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......237
1$350
   Table 94: Latin American Historic Review for Blood Banking and Blood Products by Product Group/ Segment – Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart).......2381$350
   Table 95: Latin American 10-Year Perspective for Blood Banking and Blood Products by Product Group/Segment – Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).......2391$350
  23. REST OF WORLD.......2403 $950  
   A. Market Analysis.......240
Current and Future Analysis.......240
B. Market Analytics.......240
Table 96: Rest of World Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Segment – Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......240
1$350
   Table 97: Rest of World Historic Review for Blood Banking and Blood Products by Product Segment – Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart).......2411$350
   Table 98: Rest of World 10-Year Perspective for Blood Banking and Blood Products by Product Group/Segment – Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).......2421$350
COMPETITION 642$995
  
Total Companies Profiled: 205 (including Divisions/Subsidiaries - 315)

Region/Country                 Players


The United States                136   
Canada                            15
Japan                             10
Europe                           104
     France                       10
     Germany                      25
     The United Kingdom           18
     Italy                         7
     Spain                         4
     Rest of Europe               40
Asia-Pacific (Excluding Japan)    36
Latin America                      7
Africa                             5
Middle East                        2
Click here to request a full table of contents and more details on this project.		  
 
 

© Global Industry Analysts, Inc., USA. All Rights Reserved.
Visa Master American Verisign